Only registred members can create thier own customized alerts.
-
30/09/11
ImmuPharma to update on Lupuzor trials once Cephalon's takeover is completed -
02/08/11
ImmuPharma's future partner Teva may focus on Lupuzor after its failed MS trial, says Panmure -
02/05/11
Muted response in US to Bin Laden news, ImmuPharma partner Cephalon receives second bid -
21/02/11
ImmuPharma cancer drug delivers encouraging early results -
25/10/10
ImmuPharma's N6L compound valued at 2.5x market cap by Edison Investment Research